Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

387
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
387

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Expanding Role of Artificial Intelligence in Companion Animal Care: A Systematic Review.

Animals : an open access journal from MDPI·2026
Same author

Intracardiac Echocardiography during Invasive Electrophysiological Procedures: a Scientific Statement of the European Heart Rhythm Association of the ESC, and the European Association of Percutaneous Cardiovascular Interventions of the ESC.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2026
Same author

Time to rethink ICD indications in non-ishaemic cardiomyopathy? Evidence from a meta-analysis across therapeutic eras.

ESC heart failure·2026
Same author

Durability of Exercise vs. Revascularization in Intermittent Claudication: An Updated Meta-Analysis of Randomized Trials Focusing on Patient-Centered Outcomes.

Healthcare (Basel, Switzerland)·2026
Same author

Improving Risk Stratification in Sudden Cardiac Death Using Interpretable Machine Learning: A Clinical Perspective.

Healthcare (Basel, Switzerland)·2025
Same author

Completely Fluoroless, "Apron-Less" Approach to Supraventricular Tachycardia Ablation Compared to Traditional Fluoroscopy Guided Ablation: Feasibility, Safety and Clinical Outcomes.

Journal of clinical medicine·2025

Related Experiment Video

Updated: Jan 13, 2026

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
16:40

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation

Published on: February 28, 2012

26.8K

Machine Learning-Based Risk Stratification for Sudden Cardiac Death Using Clinical and Device-Derived Data.

Hana Ivandic1, Branimir Pervan1, Mislav Puljevic2,3

  • 1University of Zagreb Faculty of Electrical Engineering and Computing, Unska 3, HR-10000 Zagreb, Croatia.

Sensors (Basel, Switzerland)
|January 10, 2026
PubMed
Summary

Machine learning models show promise in predicting sudden cardiac death (SCD) risk, improving patient selection for implantable cardioverter-defibrillators (ICDs). These models achieved high recall, identifying patients needing intervention more effectively than current methods.

Keywords:
SHAP analysisimplantable cardioverter defibrillatormachine learningsudden cardiac death

More Related Videos

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.2K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

8.0K

Related Experiment Videos

Last Updated: Jan 13, 2026

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
16:40

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation

Published on: February 28, 2012

26.8K
In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.2K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

8.0K

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Data Science

Background:

  • Sudden cardiac death (SCD) poses a significant clinical challenge.
  • Implantable cardioverter-defibrillators (ICDs) are the primary preventive measure for SCD.
  • Current patient selection for ICDs relies on imperfect risk markers.

Purpose of the Study:

  • To evaluate the potential of machine learning (ML) models in improving SCD risk prediction.
  • To utilize tabular clinical data, including ECG and ICD-derived features, for enhanced risk assessment.
  • To refine patient selection for ICD implantation using advanced predictive analytics.

Main Methods:

  • Trained various ML models (Random Forest, Naive Bayes, Logistic Regression, Voting Classifiers) on diverse patient data.
  • Included demographic, clinical, laboratory, and device-derived variables.
  • Optimized models for F2-score to prioritize high-risk patient detection and used SHAP values for interpretability.

Main Results:

  • The Random Forest model achieved the highest F2-score (0.74) and high recall (97.30%).
  • Voting Classifiers demonstrated the best overall discrimination (AUC-ROC 0.76).
  • ML models successfully identified known and potential SCD predictors, confirming their predictive capability.

Conclusions:

  • Machine learning models show significant potential for refining patient selection for ICDs.
  • The high recall achieved by ML models indicates improved detection of high-risk individuals for SCD.
  • ML-driven risk prediction offers a promising avenue to enhance cardiovascular care and reduce SCD incidence.